[1]
MATHEW, M., KILIMOZHI, D., M. MATHEWS, S. and SMITH, A. 2024. DESIGN, SYNTHESIS, AND BIO PROFILING OF 2, 3-DIHYDROQUINAZOLIN-4(1H)-ONE DERIVATIVE AS TYPE II DIABETES AGENTS: A COMPREHENSIVE IN SILICO, IN VITRO, AND IN VIVO STUDY. International Journal of Applied Pharmaceutics. 16, 6 (Nov. 2024), 329–339. DOI:https://doi.org/10.22159/ijap.2024v16i6.51705.